.png)
ICHS Members: Complimentary -
Please log in first to register
as a member.
Early Career, Low/Middle Income Countries, Global Access: Complimentary - includes a one-year membership in ICHS.
Non-members: $25USD - includes a one year ICHS membership.
Exciting online session from ICHS offering education about the new advances in CMV management! This webinar provides dynamic, interactive content on the latest updates on CMV infections from updated guidelines to the utility of measuring CMV T Cell immunity to the burden of CMV post cellular therapy, based on needs assessments and questions from the attendees.
Access this resource for a comprehensive scientific session with insights into cutting-edge research, innovative care practices, and updated guidelines with a diverse range of experts.
- Learn from the co-chair of the ECIL guidelines for CMV about the latest changes made since the last update.
- Understand the role of CMV T Cell Immunity in mitigating the risk of CMV infections in Allogeneic Cell Transplant recipients.
- Learn about the latest updates on risk of CMV infections after cellular therapy and its impact on oncologic outcomes.
Meet the Speakers:
Rafael de la Cámara, MD
Faculty Member, Hematology
Hospital de la Princesa
Hospital Universitario De La Princesa
Faculty Member
Hospital de la Zarzuela
Madrid, Spain
Biography for Dr. de la Camara - click here.
Joshua A. Hill, MD
Associate Professor, Department of Medicine, Division of Allergy and Infectious Diseases
University of Washington Medical Center
Assistant Professor, Vaccine and Infectious Disease Division, Clinical Research Division
Fred Hutchinson Cancer Center
Seattle, Washington USA
Biography for Dr. Hill - click here.
Michelle K. Yong, MBBS, FRACP, MPH, PhD
Infectious Diseases Physician
University of Melbourne
Peter MacCallum Cancer Centre
Melbourne, Australia
Biography for Dr. Yong - click here.
